Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cardiff Lexington (CDIX) Liabilities and Shareholders Equity (2016 - 2025)

Cardiff Lexington (CDIX) has 16 years of Liabilities and Shareholders Equity data on record, last reported at $27.6 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 17.41% year-over-year to $27.6 million; the TTM value through Sep 2025 reached $103.4 million, up 12.9%, while the annual FY2024 figure was $23.9 million, 15.33% up from the prior year.
  • Liabilities and Shareholders Equity reached $27.6 million in Q3 2025 per CDIX's latest filing, up from $26.5 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $27.6 million in Q3 2025 and bottomed at $5.2 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $18.1 million, with a median of $16.1 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 210.28% in 2021, then dropped 12.76% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $15.3 million in 2021, then decreased by 12.76% to $13.3 million in 2022, then surged by 55.46% to $20.7 million in 2023, then rose by 15.33% to $23.9 million in 2024, then grew by 15.4% to $27.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $27.6 million in Q3 2025, $26.5 million in Q2 2025, and $25.3 million in Q1 2025.